Back to WASATCH ADVISORS LP WASATCH ADVISORS LP

ITCIITCI
25 quarters

Position history for WASATCH ADVISORS LPWASATCH ADVISORS LP's holdings in INTRA-CELLULAR THERAPIES INC

WASATCH ADVISORS LP previously held 0 shares of ITCI (INTRA-CELLULAR THERAPIES INC), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$28.8M

Total Shares Change

-2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q4
Decreased
3.2M
-15.6%
$271.3M1.3%
0
2024-Q3
Increased
3.8M
+3.5%
$281.6M1.4%
50
2024-Q2
Decreased
3.7M
-3.5%
$254.7M1.4%
0
2024-Q1
Increased
3.9M
+6.3%
$266.7M1.4%
52
2023-Q4
Decreased
3.6M
-4.6%
$259.8M1.4%
0
2023-Q3
Increased
3.8M
+9.1%
$198.1M1.3%
53
2023-Q2
Decreased
3.5M
-22.2%
$220.7M1.3%
0
2023-Q1
Decreased
4.5M
-5.5%
$242.6M1.5%
0
2022-Q4
Decreased
4.7M
-9.6%
$250.8M1.7%
0
2022-Q3
Decreased
5.2M
-2.7%
$244M1.7%
0
2022-Q2
Decreased
5.4M
-27.9%
$307.7M1.9%
0
2022-Q1
Decreased
7.5M
-9.2%
$457.6M2.3%
0
2021-Q4
Increased
8.2M
+1.4%
$431M1.8%
50
2021-Q3
Increased
8.1M
+24.8%
$302.8M1.2%
60
2021-Q2
Decreased
6.5M
-0.3%
$265.6M1.1%
0
2021-Q1
Increased
6.5M
+3.0%
$221.4M1.0%
44
2020-Q4
Increased
6.3M
+17.1%
$201.4M1.0%
50
2020-Q3
Increased
5.4M
+47.8%
$138.8M0.9%
58
2020-Q2
Increased
3.7M
+24.8%
$94M0.7%
52
2020-Q1
Increased
2.9M
+64.6%
$45.1M0.5%
51
2019-Q4
Decreased
1.8M
-55.6%
$61.1M0.5%
0
2019-Q3
Increased
4M
+71.0%
$30M0.3%
51
2019-Q2
Decreased
2.3M
-0.6%
$30.5M0.3%
0
2019-Q1
New
2.4M
-
$28.8M0.3%
48

Other major holders of ITCI: VANGUARD GROUP INC, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used